Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$20,419,949
+$547,466 QoQ
Shares Held
80,403
-1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#730
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names. JNJ ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
|
1,600 | $303,392 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,419,949 | 80,403 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $19,872,483 | 81,298 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,863,941 | 81,488 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,224,650 | 82,109 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,104,368 | 79,243 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $13,626,906 | 82,169 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $12,030,648 | 83,188 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $14,005,387 | 86,421 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $12,426,669 | 85,021 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $13,423,528 | 84,857 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $13,678,543 | 87,269 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $13,848,667 | 88,916 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $15,056,692 | 90,966 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $14,364,005 | 92,671 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $18,307,652 | 103,638 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $17,094,807 | 104,645 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,616,361 | 104,875 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $18,707,335 | 105,554 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $18,016,237 | 105,315 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $17,188,606 | 106,431 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $17,950,235 | 108,961 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $18,055,326 | 109,859 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $17,305,190 | 109,958 | Shares | Sole | 2021-03-16 | |
| 2020-09-30 | $16,556,051 | 111,204 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,784,873 | 112,244 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $14,718,424 | 112,243 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||